

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.64044292 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.47729623 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.47729623 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.41828686 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.41828686 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.41828686 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.41828686 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.41828686 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.41828686 |
| 10 | response to peptidoglycan (GO:0032494) | 5.13003065 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 5.11144271 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.02363311 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.96949228 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.71072640 |
| 15 | detection of other organism (GO:0098543) | 4.42600076 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.39675307 |
| 17 | cellular extravasation (GO:0045123) | 4.21034328 |
| 18 | detection of bacterium (GO:0016045) | 4.19365485 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.15812843 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.10706047 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.10606605 |
| 22 | neutrophil activation (GO:0042119) | 4.07786195 |
| 23 | granulocyte activation (GO:0036230) | 4.05680527 |
| 24 | regulation of mast cell degranulation (GO:0043304) | 4.00133317 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.98616881 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.98458041 |
| 27 | negative regulation of type 2 immune response (GO:0002829) | 3.93371799 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 3.90845454 |
| 29 | detection of external biotic stimulus (GO:0098581) | 3.89647685 |
| 30 | microglial cell activation (GO:0001774) | 3.87202314 |
| 31 | leukocyte aggregation (GO:0070486) | 3.84500856 |
| 32 | positive regulation of mast cell activation (GO:0033005) | 3.79026834 |
| 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.78084859 |
| 34 | myeloid cell activation involved in immune response (GO:0002275) | 3.70702630 |
| 35 | macrophage activation (GO:0042116) | 3.68036072 |
| 36 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.68028775 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.61211871 |
| 38 | respiratory burst (GO:0045730) | 3.60384131 |
| 39 | response to host immune response (GO:0052572) | 3.54421736 |
| 40 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.54421736 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.53355957 |
| 42 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.53026174 |
| 43 | regulation of mast cell activation (GO:0033003) | 3.51817333 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.51292027 |
| 45 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.50095509 |
| 46 | positive regulation of mast cell degranulation (GO:0043306) | 3.50095509 |
| 47 | regulation of leukocyte degranulation (GO:0043300) | 3.48768824 |
| 48 | detection of biotic stimulus (GO:0009595) | 3.47700207 |
| 49 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.35499935 |
| 50 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.31988200 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.31694211 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.25813190 |
| 53 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.18170052 |
| 54 | regulation of interferon-alpha production (GO:0032647) | 3.16289781 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14983577 |
| 56 | response to host (GO:0075136) | 3.14983577 |
| 57 | response to host defenses (GO:0052200) | 3.14983577 |
| 58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.13955415 |
| 59 | regulation of type 2 immune response (GO:0002828) | 3.12369569 |
| 60 | negative regulation of T cell mediated immunity (GO:0002710) | 3.12017126 |
| 61 | defense response to protozoan (GO:0042832) | 3.11491511 |
| 62 | positive regulation of interferon-alpha production (GO:0032727) | 3.11275342 |
| 63 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.10422769 |
| 64 | B cell mediated immunity (GO:0019724) | 3.10040067 |
| 65 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.08075867 |
| 66 | negative regulation of innate immune response (GO:0045824) | 3.04910420 |
| 67 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.03108205 |
| 68 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02363986 |
| 69 | neutrophil mediated immunity (GO:0002446) | 3.00114043 |
| 70 | leukocyte degranulation (GO:0043299) | 2.99842205 |
| 71 | regulation of regulated secretory pathway (GO:1903305) | 2.99225025 |
| 72 | positive regulation of leukocyte degranulation (GO:0043302) | 2.99206389 |
| 73 | regulation of tolerance induction (GO:0002643) | 2.98484530 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 2.97126393 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96974987 |
| 76 | germinal center formation (GO:0002467) | 2.96817261 |
| 77 | type I interferon signaling pathway (GO:0060337) | 2.95777241 |
| 78 | cellular response to type I interferon (GO:0071357) | 2.95777241 |
| 79 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.94609118 |
| 80 | T-helper 1 type immune response (GO:0042088) | 2.94275667 |
| 81 | neutrophil chemotaxis (GO:0030593) | 2.94180964 |
| 82 | response to type I interferon (GO:0034340) | 2.92448301 |
| 83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92210635 |
| 84 | response to interleukin-15 (GO:0070672) | 2.91863463 |
| 85 | positive regulation of B cell differentiation (GO:0045579) | 2.91271379 |
| 86 | amino sugar catabolic process (GO:0046348) | 2.90938993 |
| 87 | regulation of antigen processing and presentation (GO:0002577) | 2.90367089 |
| 88 | response to protozoan (GO:0001562) | 2.90119123 |
| 89 | negative regulation of interleukin-6 production (GO:0032715) | 2.89881632 |
| 90 | myeloid leukocyte activation (GO:0002274) | 2.87817564 |
| 91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87430290 |
| 92 | cellular response to interleukin-15 (GO:0071350) | 2.87305566 |
| 93 | neutrophil migration (GO:1990266) | 2.86648784 |
| 94 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.83862334 |
| 95 | positive thymic T cell selection (GO:0045059) | 2.82670688 |
| 96 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.82070982 |
| 97 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.81967845 |
| 98 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.79980321 |
| 99 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.77782824 |
| 100 | N-acetylneuraminate metabolic process (GO:0006054) | 2.74966452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.41272350 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.78356342 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.54463738 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.62201863 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56117412 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.55032910 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.25254948 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17106419 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.00101222 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.81714753 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.81552147 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.79206052 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.65013229 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.60548042 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.59649929 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.50472765 |
| 17 | SPI1_23127762_ChIP-Seq_K562_Human | 2.50168797 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47432690 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.36953717 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.36894503 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35562113 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.32627279 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.29074846 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26984986 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.24552265 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.13604538 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.06870710 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.05347300 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.05153583 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.02087338 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.98333878 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97399147 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.95926564 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.83069810 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80744896 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.73755282 |
| 37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73199421 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73039315 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.73001164 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70743788 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68639105 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65780153 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55161975 |
| 44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50783552 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.50607544 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49290781 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47154335 |
| 48 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46093634 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.45600350 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45184511 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44715974 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.44526356 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.44278137 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44100921 |
| 55 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41146697 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40827268 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38765387 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38653225 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36440354 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36209247 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35708040 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35528887 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32959644 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31770452 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29962086 |
| 66 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27174028 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27103682 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25207855 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22820200 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21395035 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19646665 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19069340 |
| 73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17715610 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14966624 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14564751 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13429889 |
| 77 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12070530 |
| 78 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11742269 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11307940 |
| 80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10784139 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09647223 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08501473 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07619423 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03237767 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00854898 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99599050 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99346406 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93120371 |
| 89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92774500 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92428592 |
| 91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88216809 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86907080 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83002903 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82647252 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80851762 |
| 96 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80152307 |
| 97 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79965057 |
| 98 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.78662720 |
| 99 | P300_27268052_Chip-Seq_Bcells_Human | 0.77166660 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.76495906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.30453927 |
| 2 | MP0003303_peritoneal_inflammation | 4.20388817 |
| 3 | MP0003436_decreased_susceptibility_to | 4.07290153 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.54217764 |
| 5 | MP0005671_abnormal_response_to | 3.35087714 |
| 6 | MP0006082_CNS_inflammation | 3.28515557 |
| 7 | MP0002419_abnormal_innate_immunity | 3.21876215 |
| 8 | MP0009785_altered_susceptibility_to | 3.05589276 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.92889887 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.90244790 |
| 11 | MP0005025_abnormal_response_to | 2.87097947 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.82148853 |
| 13 | MP0001790_abnormal_immune_system | 2.69517112 |
| 14 | MP0005387_immune_system_phenotype | 2.69517112 |
| 15 | MP0001800_abnormal_humoral_immune | 2.57419504 |
| 16 | MP0002723_abnormal_immune_serum | 2.53126601 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.48881877 |
| 18 | MP0000685_abnormal_immune_system | 2.45916630 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.33689224 |
| 20 | MP0001819_abnormal_immune_cell | 2.32151942 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.26818342 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.22265874 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.19644327 |
| 24 | MP0009278_abnormal_bone_marrow | 2.19564764 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.17151147 |
| 26 | MP0009840_abnormal_foam_cell | 2.08860120 |
| 27 | MP0009764_decreased_sensitivity_to | 2.03001221 |
| 28 | MP0002405_respiratory_system_inflammati | 1.95601139 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.85330223 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.84573551 |
| 31 | MP0004947_skin_inflammation | 1.72140089 |
| 32 | MP0002998_abnormal_bone_remodeling | 1.69837789 |
| 33 | MP0004510_myositis | 1.69679237 |
| 34 | MP0003075_altered_response_to | 1.68917275 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.68544662 |
| 36 | MP0000716_abnormal_immune_system | 1.68215553 |
| 37 | MP0000343_altered_response_to | 1.63536196 |
| 38 | MP0003828_pulmonary_edema | 1.59073087 |
| 39 | MP0000604_amyloidosis | 1.59043686 |
| 40 | MP0008469_abnormal_protein_level | 1.58551882 |
| 41 | MP0000858_altered_metastatic_potential | 1.57644035 |
| 42 | MP0002398_abnormal_bone_marrow | 1.52388061 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.49309475 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.49309475 |
| 45 | MP0003690_abnormal_glial_cell | 1.49140056 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.47627874 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.46496244 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.45213207 |
| 49 | MP0005310_abnormal_salivary_gland | 1.39432423 |
| 50 | MP0001853_heart_inflammation | 1.37435097 |
| 51 | MP0001851_eye_inflammation | 1.36374816 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.35805016 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.35444320 |
| 54 | MP0005451_abnormal_body_composition | 1.34130006 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.31507057 |
| 56 | MP0002429_abnormal_blood_cell | 1.28742321 |
| 57 | MP0002722_abnormal_immune_system | 1.27523520 |
| 58 | MP0003448_altered_tumor_morphology | 1.27158594 |
| 59 | MP0008260_abnormal_autophagy | 1.23498584 |
| 60 | MP0005166_decreased_susceptibility_to | 1.22075197 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.10705198 |
| 62 | MP0008004_abnormal_stomach_pH | 1.09777056 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.03724665 |
| 64 | MP0004883_abnormal_blood_vessel | 1.00787017 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.00753441 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 1.00682720 |
| 67 | MP0009763_increased_sensitivity_to | 0.95943976 |
| 68 | MP0002132_abnormal_respiratory_system | 0.92649126 |
| 69 | MP0005390_skeleton_phenotype | 0.91971168 |
| 70 | MP0000703_abnormal_thymus_morphology | 0.90533434 |
| 71 | MP0005164_abnormal_response_to | 0.90441619 |
| 72 | MP0003866_abnormal_defecation | 0.86474961 |
| 73 | MP0001873_stomach_inflammation | 0.86282175 |
| 74 | MP0002139_abnormal_hepatobiliary_system | 0.86063242 |
| 75 | MP0001663_abnormal_digestive_system | 0.85217052 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.84214594 |
| 77 | MP0000920_abnormal_myelination | 0.78215677 |
| 78 | MP0003795_abnormal_bone_structure | 0.77317860 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 0.76992641 |
| 80 | MP0002933_joint_inflammation | 0.76978309 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 0.73518386 |
| 82 | MP0003329_amyloid_beta_deposits | 0.73212583 |
| 83 | MP0003195_calcinosis | 0.71386129 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.69798220 |
| 85 | MP0002133_abnormal_respiratory_system | 0.65273718 |
| 86 | MP0005388_respiratory_system_phenotype | 0.65273718 |
| 87 | MP0000490_abnormal_crypts_of | 0.65116147 |
| 88 | MP0000249_abnormal_blood_vessel | 0.64191846 |
| 89 | MP0008874_decreased_physiological_sensi | 0.64157072 |
| 90 | MP0002254_reproductive_system_inflammat | 0.61883133 |
| 91 | MP0002653_abnormal_ependyma_morphology | 0.61810178 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.60083281 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.59704426 |
| 94 | MP0005365_abnormal_bile_salt | 0.59490558 |
| 95 | MP0006054_spinal_hemorrhage | 0.55575330 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.54989506 |
| 97 | MP0000371_diluted_coat_color | 0.53815525 |
| 98 | MP0003011_delayed_dark_adaptation | 0.53543079 |
| 99 | MP0004381_abnormal_hair_follicle | 0.51038538 |
| 100 | MP0000609_abnormal_liver_physiology | 0.49524424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.03352851 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.03352851 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.03352851 |
| 4 | Eczematoid dermatitis (HP:0000976) | 6.01119739 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.81521708 |
| 6 | Recurrent abscess formation (HP:0002722) | 5.72182170 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.47701506 |
| 8 | Myositis (HP:0100614) | 4.79812112 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.68392722 |
| 10 | Orchitis (HP:0100796) | 4.64506760 |
| 11 | Stomatitis (HP:0010280) | 4.55319004 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.52194014 |
| 13 | Optic neuritis (HP:0100653) | 4.52194014 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 4.15229279 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.93919661 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.76312408 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.70264963 |
| 18 | Obstructive lung disease (HP:0006536) | 3.69486559 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.69486559 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.64882800 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.59932394 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.49882945 |
| 23 | Loss of speech (HP:0002371) | 3.47430430 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.45318075 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.44984778 |
| 26 | Disinhibition (HP:0000734) | 3.39361784 |
| 27 | Recurrent skin infections (HP:0001581) | 3.38905272 |
| 28 | Meningitis (HP:0001287) | 3.20503235 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.19639684 |
| 30 | Keratoconjunctivitis sicca (HP:0001097) | 3.15358676 |
| 31 | Encephalitis (HP:0002383) | 3.05264846 |
| 32 | Vasculitis (HP:0002633) | 2.99654072 |
| 33 | Gingivitis (HP:0000230) | 2.99526697 |
| 34 | Urticaria (HP:0001025) | 2.99275405 |
| 35 | Pulmonary infiltrates (HP:0002113) | 2.95664014 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.94936652 |
| 37 | Keratoconjunctivitis (HP:0001096) | 2.93308598 |
| 38 | Amyloidosis (HP:0011034) | 2.91394913 |
| 39 | Hemoptysis (HP:0002105) | 2.88906994 |
| 40 | Anorexia (HP:0002039) | 2.81796416 |
| 41 | T lymphocytopenia (HP:0005403) | 2.78797231 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.78674559 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.78674559 |
| 44 | Purpura (HP:0000979) | 2.77572857 |
| 45 | Petechiae (HP:0000967) | 2.76998603 |
| 46 | Mutism (HP:0002300) | 2.76804441 |
| 47 | Increased IgM level (HP:0003496) | 2.71445293 |
| 48 | Autoimmune thrombocytopenia (HP:0001973) | 2.64906628 |
| 49 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.63537935 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.63085075 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.63085075 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.63085075 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.61078834 |
| 54 | Axonal loss (HP:0003447) | 2.57946245 |
| 55 | Increased IgE level (HP:0003212) | 2.56833785 |
| 56 | Increased serum ferritin (HP:0003281) | 2.55721343 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.54025091 |
| 58 | Basal ganglia calcification (HP:0002135) | 2.51682199 |
| 59 | Leukocytosis (HP:0001974) | 2.48508793 |
| 60 | Mucopolysacchariduria (HP:0008155) | 2.45372691 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.45372691 |
| 62 | Chest pain (HP:0100749) | 2.36243684 |
| 63 | Pulmonary embolism (HP:0002204) | 2.33957885 |
| 64 | Episodic fever (HP:0001954) | 2.32929149 |
| 65 | Arterial thrombosis (HP:0004420) | 2.31041203 |
| 66 | Malnutrition (HP:0004395) | 2.30107260 |
| 67 | Cheilitis (HP:0100825) | 2.28813189 |
| 68 | Gangrene (HP:0100758) | 2.28734067 |
| 69 | Pustule (HP:0200039) | 2.28286750 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.26597637 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.24910896 |
| 72 | Agnosia (HP:0010524) | 2.24177272 |
| 73 | Progressive neurologic deterioration (HP:0002344) | 2.23842836 |
| 74 | Recurrent viral infections (HP:0004429) | 2.23787668 |
| 75 | Upper motor neuron abnormality (HP:0002127) | 2.22892397 |
| 76 | Gingival bleeding (HP:0000225) | 2.22097468 |
| 77 | Personality changes (HP:0000751) | 2.21787361 |
| 78 | Epistaxis (HP:0000421) | 2.19121215 |
| 79 | Neuronal loss in central nervous system (HP:0002529) | 2.17826749 |
| 80 | Premature loss of primary teeth (HP:0006323) | 2.17758727 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.17090199 |
| 82 | Abnormality of eosinophils (HP:0001879) | 2.16831403 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.16425447 |
| 84 | Inflammation of the large intestine (HP:0002037) | 2.16076799 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.15763739 |
| 86 | Cellulitis (HP:0100658) | 2.15477321 |
| 87 | Glomerulonephritis (HP:0000099) | 2.14488485 |
| 88 | Granulocytopenia (HP:0001913) | 2.13423808 |
| 89 | Abnormality of T cells (HP:0002843) | 2.09701413 |
| 90 | Hypochromic anemia (HP:0001931) | 2.08300510 |
| 91 | Polyneuropathy (HP:0001271) | 2.07014545 |
| 92 | Gastrointestinal inflammation (HP:0004386) | 2.03736145 |
| 93 | Vertigo (HP:0002321) | 2.03259746 |
| 94 | Osteomyelitis (HP:0002754) | 1.99523675 |
| 95 | Hematochezia (HP:0002573) | 1.98799859 |
| 96 | Myocardial infarction (HP:0001658) | 1.97672052 |
| 97 | Glomerulopathy (HP:0100820) | 1.97595711 |
| 98 | Abnormality of the endocardium (HP:0004306) | 1.95211828 |
| 99 | Abnormality of the pleura (HP:0002103) | 1.94546872 |
| 100 | Pathologic fracture (HP:0002756) | 1.93598413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.72877246 |
| 2 | BLK | 3.73773713 |
| 3 | MAP4K1 | 2.95449447 |
| 4 | IRAK4 | 2.78324769 |
| 5 | CSK | 2.77898644 |
| 6 | TYK2 | 2.59105490 |
| 7 | MAP3K14 | 2.53781923 |
| 8 | MAP2K3 | 2.46059045 |
| 9 | FES | 2.34490633 |
| 10 | IRAK3 | 2.31705814 |
| 11 | TXK | 2.31293991 |
| 12 | GRK6 | 2.21782831 |
| 13 | ERN1 | 2.19273117 |
| 14 | FGR | 2.18194738 |
| 15 | ZAP70 | 2.02331266 |
| 16 | TBK1 | 2.00448626 |
| 17 | TNK2 | 1.94462878 |
| 18 | PRPF4B | 1.87550626 |
| 19 | MAP3K3 | 1.83592121 |
| 20 | IKBKE | 1.80001116 |
| 21 | TGFBR2 | 1.72894413 |
| 22 | BTK | 1.72247352 |
| 23 | TAOK1 | 1.70590553 |
| 24 | JAK3 | 1.69572556 |
| 25 | MAP3K11 | 1.67964529 |
| 26 | MATK | 1.67673998 |
| 27 | TAOK3 | 1.65162090 |
| 28 | SYK | 1.64363616 |
| 29 | IKBKB | 1.61798564 |
| 30 | GRK7 | 1.60160768 |
| 31 | HCK | 1.58359602 |
| 32 | LYN | 1.47640905 |
| 33 | JAK1 | 1.47297085 |
| 34 | TAOK2 | 1.45526869 |
| 35 | BMPR2 | 1.45294984 |
| 36 | CSF1R | 1.42574718 |
| 37 | LCK | 1.29101802 |
| 38 | KIT | 1.24877386 |
| 39 | MAP3K13 | 1.23765886 |
| 40 | MARK3 | 1.16333355 |
| 41 | JAK2 | 1.12172311 |
| 42 | EPHB1 | 1.05254146 |
| 43 | MAP3K1 | 1.03902906 |
| 44 | SIK3 | 1.02996200 |
| 45 | TESK2 | 0.99324544 |
| 46 | STK10 | 0.85831254 |
| 47 | PDK1 | 0.81915783 |
| 48 | MOS | 0.81063738 |
| 49 | MUSK | 0.80949898 |
| 50 | IRAK2 | 0.80752417 |
| 51 | ITK | 0.77952449 |
| 52 | CDC42BPA | 0.76160369 |
| 53 | KSR2 | 0.76119075 |
| 54 | NME2 | 0.75348729 |
| 55 | CAMKK2 | 0.73865255 |
| 56 | PDPK1 | 0.73268530 |
| 57 | RPS6KL1 | 0.70583582 |
| 58 | RPS6KC1 | 0.70583582 |
| 59 | MAP2K2 | 0.69932231 |
| 60 | PIM1 | 0.69625737 |
| 61 | IRAK1 | 0.69296500 |
| 62 | TEC | 0.67558749 |
| 63 | YES1 | 0.67426427 |
| 64 | PRKD2 | 0.66319866 |
| 65 | RPS6KA6 | 0.62492984 |
| 66 | DAPK2 | 0.62240923 |
| 67 | MAPK7 | 0.60803967 |
| 68 | RPS6KA2 | 0.60417793 |
| 69 | FYN | 0.60090165 |
| 70 | MAP3K5 | 0.59924399 |
| 71 | MAP3K6 | 0.56424292 |
| 72 | MARK2 | 0.54696923 |
| 73 | SIK2 | 0.53144263 |
| 74 | ACVR1B | 0.51755495 |
| 75 | TLK1 | 0.51468489 |
| 76 | MAPK12 | 0.49350629 |
| 77 | SGK3 | 0.45859711 |
| 78 | ADRBK2 | 0.45850603 |
| 79 | DDR2 | 0.45217100 |
| 80 | MAP2K6 | 0.44604257 |
| 81 | PRKCQ | 0.43048409 |
| 82 | ABL1 | 0.41597392 |
| 83 | CHUK | 0.37700779 |
| 84 | ABL2 | 0.37276448 |
| 85 | CDK4 | 0.36479082 |
| 86 | CAMK1D | 0.35289171 |
| 87 | RPS6KA1 | 0.34895325 |
| 88 | LRRK2 | 0.33309051 |
| 89 | CDK6 | 0.32891792 |
| 90 | MAPK4 | 0.32758696 |
| 91 | PRKCD | 0.32421606 |
| 92 | PTK6 | 0.31491070 |
| 93 | ARAF | 0.30604062 |
| 94 | STK11 | 0.30266991 |
| 95 | SGK2 | 0.29707815 |
| 96 | PIK3CG | 0.29697631 |
| 97 | MAPKAPK2 | 0.27922799 |
| 98 | MAP3K2 | 0.27249098 |
| 99 | INSR | 0.23906967 |
| 100 | EGFR | 0.23008358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.24728516 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.06816105 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04518102 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.59122007 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.58681308 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.52213894 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.34546003 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.28585176 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.26755009 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.24955534 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.08132784 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.07550828 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.07375430 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.05512529 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.02804656 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.01416831 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97293464 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.87182486 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85772490 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.83981111 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.83921543 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81222631 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79280289 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.70739580 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67989974 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.67193513 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.66066420 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.64043423 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63373396 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58110096 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49959242 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49453526 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48867110 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.43862700 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43680242 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42362023 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.38777870 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.31857973 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.30444543 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.28357347 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20556551 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19956466 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18386997 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17827924 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17397188 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15126012 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12049784 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12029370 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07214571 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 1.01033994 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95262752 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.88000245 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.87981698 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83756525 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83518809 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.81752020 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81711650 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79902308 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71246092 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.69628854 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.69063301 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65024948 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64266885 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63441539 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.60123852 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56003905 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53363647 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52977453 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52373102 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49496408 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46496847 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.45473674 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43898606 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.43865602 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43776529 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42916067 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40976993 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39532105 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.39525063 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39237209 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37988240 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37474164 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36459235 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36335303 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34956492 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33332666 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.33100740 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31967945 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27859123 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27441509 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27160577 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27117400 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26875786 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26149982 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25145729 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24941214 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24760854 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.20086456 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.18857540 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.18341307 |

